Fampridine for MS responders: clinically relevant or hypothesis generating?
- PMID: 18672471
- DOI: 10.1212/01.wnl.0000326215.57202.2d
Fampridine for MS responders: clinically relevant or hypothesis generating?
Comment on
-
Dose comparison trial of sustained-release fampridine in multiple sclerosis.Neurology. 2008 Oct 7;71(15):1134-41. doi: 10.1212/01.wnl.0000326213.89576.0e. Epub 2008 Jul 30. Neurology. 2008. PMID: 18672472 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical